Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot vs. surgeon: which surgery is safer for pelvic organ prolapse?

NCT ID NCT01320215

Completed Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared two types of minimally invasive surgery for pelvic organ prolapse in 365 women. One group had robot-assisted surgery, while the other had standard laparoscopic surgery without a robot. The main goal was to see which approach had fewer complications within 30 days after the operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
robot-assisted or non-robot laparoscopic surgery
What this could lead to
If robot-assisted surgery proves safer, it could become the preferred option for pelvic organ prolapse repair, reducing complications and improving recovery.
What could go wrong
This is a completed trial comparing two surgical techniques, not a new treatment. Results may show no significant difference, and individual outcomes vary based on surgeon skill and patient factors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pelvic organ prolapse Uterine Prolapse

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PELVIC ORGAN PROLAPSE

Contacts and locations

Locations

  • APHP - Centre Hospitalier Henri Mondor

    Créteil, 94000, France

  • APHP - Groupe Hospitalier Pitié-Salpetrière

    Paris, 75651, France

  • CHRU de Strasbourg - Hôpital Civil

    Strasbourg, 67091, France

  • CHRU de Toulouse - Hôpital de Rangueil

    Toulouse, 31059, France

  • CHRU de Tours - Hôpital Bretonneau

    Tours, 37044, France

  • CHU de Dijon

    Dijon, 21079, France

  • CHU de Lyon - Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69310, France

  • CHU de Montpellier - Hôpital Lapeyronie

    Montpellier, 34295, France

  • CHU de Nancy - Hôpitaux de Brabois

    Nancy, France

  • CHU de Nantes

    Nantes, 44000, France

  • CHU de Nice - Hôpitaux L'Archet 1 et 2

    Nice, 06202, France

  • CHU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, Gard, 30029, France

  • CHU de Rennes - Hôpital PontChaillou

    Rennes, 35033, France

  • Clinique Belledonne

    Saint Martin d'Héres, 38400, France

  • Clinique Kennedy

    Nîmes, 30900, France

  • Groupe Hospitalier Diaconesses Croix Saint-Simon - Site Reuilly

    Paris, 75012, France

  • Groupe Urologie Saint Augustin

    Bordeaux, 33074, France

  • Hôpital Foch

    Suresnes, 92151, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.